Press release
Nuclear Medicine/Radiopharmaceuticals Market Set to Achieve Staggering Growth, Valued at US$ 5.55 Billion in 2022
Nuclear Medicine/Radiopharmaceuticals Market
The global Nuclear Medicine/Radiopharmaceuticals market has witnessed substantial growth, with an estimated value of US$ 5.55 billion in 2022. The market is poised for remarkable expansion, projecting a Compound Annual Growth Rate (CAGR) of 9% and aiming to reach an impressive US$ 10.14 billion by 2029. This comprehensive report provides a detailed analysis of the industry, covering market trends, key drivers, restraints, and regional insights.
The report employs a rigorous research methodology, utilizing both primary and secondary sources of data. Key opinion leaders (KOLs) from both demand and supply sides were interviewed to obtain unbiased insights. Country-level data was then aggregated to provide a global perspective of the Nuclear Medicine/Radiopharmaceuticals market.
For detail insights on this market, request for methodology here @ https://www.maximizemarketresearch.com/market-report/global-nuclear-medicine-radiopharmaceuticals-market/7741/
What are Nuclear Medicine/Radiopharmaceuticals Market Dynamics?
Rising Incidence of Cancer and Cardiac Ailments: Increasing prevalence of cancer and cardiac conditions are driving the demand for Nuclear Medicine/Radiopharmaceuticals, providing advanced diagnostic and treatment options.
Technological Advancements: Innovations in nuclear medicine equipment and procedures are spurring market growth, enabling enhanced diagnosis and treatment of diseases.
Market Restraints: The high cost associated with nuclear medicine equipment may pose a constraint to market expansion. However, advancements in technology are expected to alleviate this challenge over time.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary +
TOC]) @ https://www.maximizemarketresearch.com/request-sample/7741
What is Nuclear Medicine/Radiopharmaceuticals Market Segmentation?
by Procedures
Cardiovascular
Oncology
Central Nervous System
Skeletal
Endocrine
Gastrointestinal
Pulmonary
by Type
Therapeutic
Alpha Emitters
Beta Emitters
Brachytherapy Isotopes
Diagnostic
PET Radiopharmaceuticals
SPECT Radiopharmaceuticals
by Application
Cardiology
Oncology
Thyroid
Neurology
Others
by End-User
Research Institutes
Hospitals
Diagnostic Centers
Others
For any Queries Linked with the Report, Ask an Analyst@ https://www.maximizemarketresearch.com/inquiry-before-buying/7741
Who are Nuclear Medicine/Radiopharmaceuticals Market Key Players?
1. Advanced Accelerator Applications S.A.
2. Iba Molecular
3. Nordion, Inc. (A Subsidiary of Sterigenics International LLC.)
4. Eczacibasi-Monrol Nuclear Products
5. Siemens Healthcare
6. Sigma Aldrich Corporation
7. Bracco Imaging S.P.A
8. Bayer AG
9. Jubilant Pharma
10.Nordien, Inc.
11.Lantheus Medical Imaging, Inc.
12.GE Healthcare (A Fully-Owned Subsidiary of General Electric Company)
13.Mallinckrodt PLC
14.Cardinal Health, Inc.
15.Medtronic Plc.
16.Norgine B. V.
17.Curium
18.Eckert & Ziegler
19.NTP Radioisotopes
Please connect with our representative, who will ensure you to get a report sample here @ https://www.maximizemarketresearch.com/request-sample/7741
Table of content for the Nuclear Medicine/Radiopharmaceuticals Market includes:
Part 01: Executive Summary
Part 02: Scope of the Nuclear Medicine/Radiopharmaceuticals Market Report
Part 03: Global Nuclear Medicine/Radiopharmaceuticals Market Landscape
Part 04: Global Nuclear Medicine/Radiopharmaceuticals Market Sizing
Part 05: Global Nuclear Medicine/Radiopharmaceuticals Market Segmentation by Type
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Regional Insights:
North America Takes Lead: North America leads the global Nuclear Medicine/Radiopharmaceuticals market, driven by a well-established healthcare industry and increasing adoption of advanced diagnostic procedures.
Potential Growth in Asia Pacific: The Asia Pacific region is poised for significant growth, fueled by rising disposable income, increasing demand for advanced healthcare technology, and modernization efforts in the security sector.
Key Offerings:
Past Market Size and Competitive Landscape (2018 to 2022)
Past Pricing and price curve by region (2018 to 2022)
Market Size, Share, Size & Forecast by different segment | 2023-2029
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
Market Segmentation - A detailed analysis by Product
Competitive Landscape - Profiles of selected key players by region from a strategic
perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations
Related Reports:
Nuclear Medicine/Radiopharmaceuticals Market https://www.maximizemarketresearch.com/market-report/global-Nuclear Medicine/Radiopharmaceuticals-market/26727/
Oligonucleotide Synthesis Market https://www.maximizemarketresearch.com/market-report/global-oligonucleotide-synthesis-market/31248/
Heparin Market https://www.maximizemarketresearch.com/market-report/global-heparin-market/103436/
Digital Health Market https://www.maximizemarketresearch.com/market-report/global-digital-health-market/3311/
Global Big Data and Data Engineering Services Market https://www.maximizemarketresearch.com/market-report/big-data-and-data-engineering-services-market/14625/
Global Nuclear Medicine/Radiopharmaceuticals Market https://www.maximizemarketresearch.com/market-report/global-fall-detection-system-market/25573/
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
444 West Lake Street, Floor 17,
Chicago, IL, 60606, USA.
+1 800 507 4489
+91 9607365656
sales@maximizemarketresearch.com
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nuclear Medicine/Radiopharmaceuticals Market Set to Achieve Staggering Growth, Valued at US$ 5.55 Billion in 2022 here
News-ID: 3206422 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
ERP Software Market Outlook: Enterprise Adoption and Digital Transformation Impa …
ERP Software Market was valued US$ 51.21 Bn in 2023 and is expected to reach US$ 113.08 Bn by 2030, at a CAGR of 11.98 % during a forecast period.
The ERP Software Market is witnessing steady growth as organizations focus on integrating core business processes into unified digital platforms. Enterprises across manufacturing, retail, healthcare, and finance are adopting ERP solutions to improve operational visibility, streamline workflows, and enhance decision-making through…
Luxury Furniture Market Analysis by Product Type, Distribution Channel, and Regi …
In an age where interiors speak louder than words, the Luxury Furniture Market is experiencing an exhilarating upturn. Discerning consumers across the globe are demanding more than just utility - they want craftsmanship, exclusivity, sustainability, and style that elevates their living spaces to art. This surge in affluent lifestyles is fueling one of the most promising segments in the global furniture landscape, with robust CAGR projections and vast opportunities waiting…
Saffron Market Set to Reach USD 2.11 Billion by 2032, Growing at 7.3% CAGR
Saffron Market: Growth, Dynamics, and Future Outlook
The Global Saffron Market size was valued at USD 610.40 Million in 2024, and the total Saffron Market revenue is expected to grow at a CAGR of 6.9% from 2025 to 2032, reaching nearly USD 1,040.30 Million by 2032.
Market Overview
The Saffron Market represents a premium segment of the global spices and food ingredients industry. Known for its distinctive aroma, color, and medicinal properties, saffron…
Digital Transformation Market Research Report: Strategic Insights and Forecast
Digital Transformation Market size was valued at USD 634.06 billion in 2023 and the total Global Digital Transformation revenue is expected to grow at a CAGR of 23.6 % from 2024 to 2030, reaching nearly USD 2794.24 billion.
The Digital Transformation Market is expanding rapidly as organizations across industries adopt advanced technologies to enhance operational efficiency, customer experience, and business agility. Enterprises are increasingly investing in cloud computing, artificial intelligence, big…
More Releases for Radiopharmaceuticals
Radiopharmaceuticals Market Size, Share | Forecast - 2033
The new report published by The Business Research Company, titled Radiopharmaceuticals Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the radiopharmaceuticals market size has grown steadily in recent years. It will grow from $6.46 billion in 2023 to…
Radiopharmaceuticals Market - Harnessing the Power of Radiopharmaceuticals for P …
Newark, New Castle, USA: The "Radiopharmaceuticals Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Radiopharmaceuticals Market: https://www.growthplusreports.com/report/radiopharmaceuticals-market/7842
This latest report researches the industry structure, sales, revenue, price and…
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029
The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors.
Market Analysis and Size
The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029.
Gets a Sample Copy of the Nuclear…
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Global Radiopharmaceutical Market Overview
1.1 Current Market Scenario
1.2 Diagnostic & Therapeutic Radiopharmaceuticals
1.3 Global Radiopharmaceticals Clinical Pipeline Overview
2. Global Radiopharmaceuticals Market Dynamics
3. Radioisotopes Used in Radiopharmaceuticals
4. EMA Guidelines for Radiopharmaceuticals
4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products
4.2 Toxicological & Pharmacological Tests
4.3 Clinical Documentation
4.4 Radiation…
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use…
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a…
